New Antiepileptic Drugs : Comparison of Key Clinical Trials
スポンサーリンク
概要
- 論文の詳細を見る
- 1999-05-01
著者
-
CRAMER Joyce
Yale University School of Medicine
-
FRENCH Jacqueline
University of Pennsylvania
-
MATTSON Richard
Yale University School of Medicine
-
Ben-menachem Elinor
Gothenburg University
-
Fisher Robert
Barrow Neurological Institute And University Of Arizona
-
Fisher Robert
Barrow Neurological Inatitute Phoenix
関連論文
- てんかん患者用QOL質問票(QOLIE-31-P)日本語版の言語的妥当性の検討
- Efficacy and Tolerability of the New Antiepileptic Drugs, II : Treatment of Refractory Epilepsy : Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
- Efficacy and Tolerability of the New Antiepileptic Drugs, I : Treatment of New-Onset Epilepsy : Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
- Development of the Quality of Life in Epilepsy Inventory for Adolescents : The QOLIE-AD-48
- Medial Temporal Lobe Epilepsy : Videotape Analysis of Objective Clinical Seizure Characteristics
- Bilateral Temporal Hypometabolism in Epilepsy
- Clobazam, Oxcarbazepine, Tiagabine, Topiramete, and Other New Antiepeleptic Drugs
- New Antiepileptic Drugs : Comparison of Key Clinical Trials
- Adding Lamotrigine to Valproate : Incidence of Rash and Other Adverse Effects
- Introduction
- Efficacy and Adverse Effects of Established and New Antiepileptic Drugs
- The Potential for Vigabatrin-Induced Intramyelinic Edema in Humans
- The Impact of Epilepsy on Health Status among Younger and Older Adults
- Letters to the Editor
- The Short-Term Impact of Adjunctive Tiagabine on Health-Related Quality of Life